Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,483
archived clinical trials in
Influenza

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
A Phase III, Randomized, Multinational Study, Double-blinded for the Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals' Haemophilus Influenzae Type b and Neisseria Meningitidis Serogroups C and Y-tetanus Toxoid Conjugate Vaccine Combined (Hib-MenCY-TT) Compared to Monovalent Hib Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.
Status: Enrolling
Updated:  12/31/1969
7513
mi
from 91732
Randwick,
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
A Phase III, Randomized, Multinational Study, Double-blinded for the Immunogenicity and Consistency Evaluation of 3 Hib-MenCY-TT Vaccine Lots and Single-blinded and Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals' Haemophilus Influenzae Type b and Neisseria Meningitidis Serogroups C and Y-tetanus Toxoid Conjugate Vaccine Combined (Hib-MenCY-TT) Compared to Monovalent Hib Vaccine in Healthy Infants at 2, 4, 6, and 12 to 15 Months of Age.
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
7513
mi
from 91732
Randwick,
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Hollywood, FL
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
US135
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2132
mi
from 91732
Savannah, GA
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US045
2132
mi
from 91732
Savannah, GA
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
1931
mi
from 91732
Stockbridge, GA
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US013
1931
mi
from 91732
Stockbridge, GA
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Rockville, MD
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
US138
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
1243
mi
from 91732
Norfolk, NE
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US025
1243
mi
from 91732
Norfolk, NE
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
1301
mi
from 91732
Omaha, NE
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US018
1301
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2210
mi
from 91732
Cary, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US078
2210
mi
from 91732
Cary, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2218
mi
from 91732
Raleigh, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US108
2218
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Salisbury, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
US137
mi
from 91732
Salisbury, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2093
mi
from 91732
Statesville, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US132
2093
mi
from 91732
Statesville, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2275
mi
from 91732
Wilmington, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US071
2275
mi
from 91732
Wilmington, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
2122
mi
from 91732
Winston-Salem, NC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US063
2122
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Moncks Corner, SC
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
US056
mi
from 91732
Moncks Corner, SC
Click here to add this to my saved trials
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated:  12/31/1969
1299
mi
from 91732
Dakota Dunes, SD
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults
Phase 2 Clinical Trial to Confirm the Dose and Formulation of a Recombinant Quadrivalent Nanoparticle Influenza Vaccine (Quad-NIV) With or Without Matrix-M1™ Adjuvant in Healthy Adults ≥ 65 Years of Age
Status: Enrolling
Updated: 12/31/1969
Research Site US050
1299
mi
from 91732
Dakota Dunes, SD
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
1786
mi
from 91732
Huntsville, AL
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1786
mi
from 91732
Huntsville, AL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
20
mi
from 91732
Anaheim, CA
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
20
mi
from 91732
Anaheim, CA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
2321
mi
from 91732
Miami, FL
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
1930
mi
from 91732
Stockbridge, GA
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1930
mi
from 91732
Stockbridge, GA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
1331
mi
from 91732
Lenexa, KA
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1331
mi
from 91732
Lenexa, KA
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
911
mi
from 91732
Missoula, MT
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
911
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
214
mi
from 91732
Las Vegas, NV
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
214
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated:  12/31/1969
2941
mi
from 91732
Halifax,
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
A Trial to Evaluate the Safety & Immunogenicity of Investigational Influenza Vaccine GSK1557484A in Adults 18-64 Yrs of Age
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2941
mi
from 91732
Halifax,
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1777
mi
from 91732
Birmingham, AL
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1447
mi
from 91732
Benton, AR
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1447
mi
from 91732
Benton, AR
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
24
mi
from 91732
Huntington Beach, CA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
24
mi
from 91732
Huntington Beach, CA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
15
mi
from 91732
Paramount, CA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
15
mi
from 91732
Paramount, CA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
4
mi
from 91732
West Covina, CA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
4
mi
from 91732
West Covina, CA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1908
mi
from 91732
Marietta, GA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1908
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1907
mi
from 91732
Woodstock, GA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1907
mi
from 91732
Woodstock, GA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1673
mi
from 91732
DeKalb, IL
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1673
mi
from 91732
DeKalb, IL
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1183
mi
from 91732
Newton, KA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1183
mi
from 91732
Newton, KA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1186
mi
from 91732
Wichita, KA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1186
mi
from 91732
Wichita, KA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2573
mi
from 91732
Woburn, MA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2573
mi
from 91732
Woburn, MA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1787
mi
from 91732
Stevensville, MI
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1787
mi
from 91732
Stevensville, MI
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1570
mi
from 91732
Saint Louis, MO
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1570
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
213
mi
from 91732
Henderson, NV
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
213
mi
from 91732
Henderson, NV
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2317
mi
from 91732
Cortland, NY
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2317
mi
from 91732
Cortland, NY
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2320
mi
from 91732
Syracuse, NY
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2211
mi
from 91732
Cary, NC
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2211
mi
from 91732
Cary, NC
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2217
mi
from 91732
Raleigh, NC
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2217
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2079
mi
from 91732
Austintown, OH
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2079
mi
from 91732
Austintown, OH
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
778
mi
from 91732
Albany, OR
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
778
mi
from 91732
Albany, OR
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2116
mi
from 91732
Erie, PA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2116
mi
from 91732
Erie, PA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2096
mi
from 91732
Hermitage, PA
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2096
mi
from 91732
Hermitage, PA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
2184
mi
from 91732
Charleston, SC
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
2184
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1211
mi
from 91732
Austin, TX
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
552
mi
from 91732
Orem, UT
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
552
mi
from 91732
Orem, UT
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated:  12/31/1969
550
mi
from 91732
Provo, UT
Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children
Immunogenicity & Safety Study of GSK Biologicals' Thimerosal-free Trivalent Influenza Vaccine (TIV) Versus a Licensed Comparator in Children
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
550
mi
from 91732
Provo, UT
Click here to add this to my saved trials